CNTA logo

Centessa Pharmaceuticals plc (CNTA) Cash from operations

annual CFO:

-$142.11M+$18.85M(+11.71%)
December 31, 2024

Summary

  • As of today (September 16, 2025), CNTA annual cash flow from operations is -$142.11 million, with the most recent change of +$18.85 million (+11.71%) on December 31, 2024.
  • During the last 3 years, CNTA annual CFO has fallen by -$5.97 million (-4.39%).

Performance

CNTA Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

quarterly CFO:

-$22.92M+$34.55M(+60.12%)
June 1, 2025

Summary

  • As of today (September 16, 2025), CNTA quarterly cash flow from operations is -$22.92 million, with the most recent change of +$34.55 million (+60.12%) on June 1, 2025.
  • Over the past year, CNTA quarterly CFO has increased by +$17.71 million (+43.59%).
  • CNTA quarterly CFO is now -80.94% below its all-time high of -$12.67 million, reached on March 31, 2021.

Performance

CNTA quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

TTM CFO:

-$144.61M+$17.71M(+10.91%)
June 1, 2025

Summary

  • As of today (September 16, 2025), CNTA TTM cash flow from operations is -$144.61 million, with the most recent change of +$17.71 million (+10.91%) on June 1, 2025.
  • Over the past year, CNTA TTM CFO has increased by +$1.76 million (+1.21%).
  • CNTA TTM CFO is now -1041.72% below its all-time high of -$12.67 million, reached on March 31, 2021.

Performance

CNTA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CNTA Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.7%+43.6%+1.2%
3 y3 years-4.4%+61.5%+27.4%
5 y5 years-2339.7%--

CNTA Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.4%+29.1%-5.1%+61.5%-10.6%+29.1%
5 y5-year<-9999.0%+29.1%-80.9%+61.5%-1041.7%+29.1%
alltimeall time<-9999.0%+29.1%-80.9%+61.5%-1041.7%+29.1%

CNTA Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$22.92M(-60.1%)
-$144.61M(-10.9%)
Mar 2025
-
-$57.47M(+35.5%)
-$162.32M(+14.2%)
Dec 2024
-$142.11M(-11.7%)
-$42.41M(+94.5%)
-$142.11M(+8.6%)
Sep 2024
-
-$21.81M(-46.3%)
-$130.80M(-10.6%)
Jun 2024
-
-$40.63M(+9.0%)
-$146.37M(-2.4%)
Mar 2024
-
-$37.26M(+19.8%)
-$149.96M(-6.8%)
Dec 2023
-$160.96M(-19.7%)
-$31.10M(-16.8%)
-$160.96M(-11.8%)
Sep 2023
-
-$37.38M(-15.4%)
-$182.58M(-0.5%)
Jun 2023
-
-$44.21M(-8.4%)
-$183.42M(-7.7%)
Mar 2023
-
-$48.27M(-8.4%)
-$198.70M(-0.9%)
DateAnnualQuarterlyTTM
Dec 2022
-$200.42M(+47.2%)
-$52.71M(+37.9%)
-$200.42M(-1.8%)
Sep 2022
-
-$38.22M(-35.8%)
-$204.00M(+2.5%)
Jun 2022
-
-$59.50M(+19.0%)
-$199.10M(+14.8%)
Mar 2022
-
-$49.99M(-11.2%)
-$173.47M(+27.4%)
Dec 2021
-$136.14M(<-9900.0%)
-$56.29M(+68.9%)
-$136.14M(+70.5%)
Sep 2021
-
-$33.32M(-1.6%)
-$79.85M(+71.6%)
Jun 2021
-
-$33.87M(+167.4%)
-$46.53M(+267.4%)
Mar 2021
-
-$12.67M
-$12.67M
Dec 2020
$0.00(-100.0%)
-
-
Dec 2019
-$5.83M
-
-

FAQ

  • What is Centessa Pharmaceuticals plc annual cash flow from operations?
  • What is the all time high annual CFO for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc annual CFO year-on-year change?
  • What is Centessa Pharmaceuticals plc quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc quarterly CFO year-on-year change?
  • What is Centessa Pharmaceuticals plc TTM cash flow from operations?
  • What is the all time high TTM CFO for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc TTM CFO year-on-year change?

What is Centessa Pharmaceuticals plc annual cash flow from operations?

The current annual CFO of CNTA is -$142.11M

What is the all time high annual CFO for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high annual cash flow from operations is $0.00

What is Centessa Pharmaceuticals plc annual CFO year-on-year change?

Over the past year, CNTA annual cash flow from operations has changed by +$18.85M (+11.71%)

What is Centessa Pharmaceuticals plc quarterly cash flow from operations?

The current quarterly CFO of CNTA is -$22.92M

What is the all time high quarterly CFO for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high quarterly cash flow from operations is -$12.67M

What is Centessa Pharmaceuticals plc quarterly CFO year-on-year change?

Over the past year, CNTA quarterly cash flow from operations has changed by +$17.71M (+43.59%)

What is Centessa Pharmaceuticals plc TTM cash flow from operations?

The current TTM CFO of CNTA is -$144.61M

What is the all time high TTM CFO for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high TTM cash flow from operations is -$12.67M

What is Centessa Pharmaceuticals plc TTM CFO year-on-year change?

Over the past year, CNTA TTM cash flow from operations has changed by +$1.76M (+1.21%)
On this page